Literature DB >> 15919774

Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome.

Birol Vural1, Eray Caliskan, Erkan Turkoz, Teoman Kilic, Ali Demirci.   

Abstract

BACKGROUND: The aim of this study was to evaluate metabolic syndrome frequency, cardiovascular risk profile and premature carotid artery atherosclerosis in patients with polycystic ovary syndrome (PCOS) especially during early adulthood.
METHODS: A case-control study was conducted on 43 young women (18-22 years of age) with PCOS and 43 age-matched volunteer controls. Anthropometrical measurements, hormone levels, lipid and glucose profile were obtained from all subjects. Two different criteria were used to assess metabolic syndrome (MS) frequency. Common carotid artery intima-media thickness (IMT) was measured and stepwise multiple linear regression analysis was used to identify the independent cardiovascular risk factors that predict IMT.
RESULTS: MS was diagnosed in 11.6% (n = 5) of women with PCOS compared to no cases in the control group (P = 0.02). The mean IMT was significantly higher in PCOS subjects (0.746 +/- 0.106 mm) compared to controls (0.608 +/- 0.105 mm, P < 0.001). Among many cardiovascular risk factors evaluated, the diagnosis of PCOS, increased body mass index and decreased sex hormone-binding globulin were significant independent predictors of increased IMT.
CONCLUSIONS: These findings indicate that adolescence may be a more appropriate time to intervene for PCOS patients, as many cardiovascular risks are already present during early adulthood. As far as IMT is concerned, mechanisms other than hyperandrogenaemia and obesity might be operating as causative factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919774     DOI: 10.1093/humrep/dei100

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  30 in total

Review 1.  [Polycystic ovary syndrome. Prototype of a cardio-metabolic syndrome].

Authors:  D Heutling; H Schulz; H Randeva; C Dodt; H Lehnert
Journal:  Internist (Berl)       Date:  2007-02       Impact factor: 0.743

Review 2.  The metabolic syndrome in polycystic ovary syndrome.

Authors:  P A Essah; J E Nestler
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

3.  Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.

Authors:  Sonali S Patel; Uyen Truong; Martina King; Annie Ferland; Kerrie L Moreau; Jennifer Dorosz; John E Hokanson; Hong Wang; Gregory L Kinney; David M Maahs; Robert H Eckel; Kristen J Nadeau; Melanie Cree-Green
Journal:  Vasc Med       Date:  2017-01-17       Impact factor: 3.239

Review 4.  Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Michelle L Meyer; Angela M Malek; Robert A Wild; Mary T Korytkowski; Evelyn O Talbott
Journal:  Hum Reprod Update       Date:  2011-11-22       Impact factor: 15.610

5.  The diagnosis of polycystic ovary syndrome in adolescents.

Authors:  Andrea Hsu Roe; Anuja Dokras
Journal:  Rev Obstet Gynecol       Date:  2011

6.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

7.  Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdogan; Ayhan Zengi; Zuhal Eroglu; Sadik Tamsel; Murat Olukman; Fusun Saygili; Candeger Yilmaz
Journal:  Endocrine       Date:  2010-07-09       Impact factor: 3.633

8.  Comparison of metabolic and obesity biomarkers between adolescent and adult women with polycystic ovary syndrome.

Authors:  Sebastião Freitas de Medeiros; Matheus Antônio Souto de Medeiros; Bruna Barcelo Barbosa; Márcia Marly Winck Yamamoto; Gustavo Arantes Rosa Maciel
Journal:  Arch Gynecol Obstet       Date:  2020-11-17       Impact factor: 2.344

9.  Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome.

Authors:  P A Essah; J E Nestler; E Carmina
Journal:  J Endocrinol Invest       Date:  2008-01       Impact factor: 4.256

10.  Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome.

Authors:  Mahjoob Vahedi; Arastoo Saeedi; Seyedeh Leila Poorbaghi; Masood Sepehrimanesh; Mohammadreza Fattahi
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-10       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.